Quarterly report pursuant to Section 13 or 15(d)

Note 11 - Stock Based Compensation - Stock Option Activity (Details)

v3.24.3
Note 11 - Stock Based Compensation - Stock Option Activity (Details) - The 2023 Equity Plan [Member] - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Outstanding (in shares) 465,500 465,500 465,500 0
Outstanding, weighted average exercise price (in dollars per share) $ 9.36 $ 9.36 $ 9.36 $ 0
Granted, options (in shares) 0 0 0 465,500
Granted, weighted average exercise price (in dollars per share) $ 0 $ 0 $ 0 $ 9.36
Forfeited, options (in shares) 0 0 0 0
Forfeited, weighted average exercise price (in dollars per share) $ 0 $ 0 $ 0 $ 0
Exercisable, options (in shares) 88,500 0 88,500 0
Exercisable, weighted average exercise price (in dollars per share) $ 9.36 $ 9.36
Exercised, options (in shares) 23,000   23,000  
Exercised, weighted average exercise price (in dollars per share) $ 9.36   $ 9.36  
Outstanding, aggregate intrinsic value [1] $ 438   $ 438  
Exercisable, aggregate intrinsic value [1] $ 88   $ 88  
Outstanding (in shares) 442,500 465,500 442,500 465,500
Outstanding, weighted average exercise price (in dollars per share) $ 9.36 $ 9.36 $ 9.36 $ 9.36
[1] Dollars in thousands. The aggregate intrinsic value of outstanding and exercisable options at September 30, 2023 and 2024 were calculated based on the closing market price of the Company's common stock of September 30, 2023 and 2024 of $10.35 and $9.05, respectively, per share less the exercise price.